Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CDNS
|
Anirudh Devgan
President and CEO |
SELL
Bona fide gift
|
Direct | 16 Reduced 0.02% |
$4,235
$264.72 p/Share
|
Sep 11
2024 |
CWH
|
Marcus Lemonis
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 121,450 Reduced 0.0% |
$2,647,610
$21.8 p/Share
|
Sep 11
2024 |
BTSG
|
Walgreens Boots Alliance, Inc. |
SELL
Open market or private sale
|
Indirect | 11,619,998 Reduced 0.0% |
-
|
Sep 11
2024 |
UP
|
Gregory L Summe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 87,688 Added 50.0% |
-
|
Sep 11
2024 |
SKYE
|
Andrew J. Schwab |
SELL
Open market or private sale
|
Indirect | 252,500 Reduced 0.0% |
$1,666,500
$6.6 p/Share
|
Sep 11
2024 |
LTRX
|
Bernhard Bruscha
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 47,903 Reduced 0.0% |
$197,360
$4.12 p/Share
|
Sep 11
2024 |
SKYE
|
5 Am Partners Vii, LLC |
SELL
Open market or private sale
|
Indirect | 252,500 Reduced 0.0% |
$1,666,500
$6.6 p/Share
|
Sep 11
2024 |
GLUE
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct | 541,897 Reduced 7.97% |
$3,251,382
$6.0 p/Share
|
Sep 11
2024 |
HTLD
|
Michael J Gerdin
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.0% |
$583,500
$11.67 p/Share
|
Sep 11
2024 |
SMMT
|
Robert W Duggan
Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,325,991 Added 0.6% |
$75,499,995
$22.7 p/Share
|
Sep 11
2024 |
CDTX
|
Leslie Tari
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 909 Reduced 4.86% |
$10,580
$11.64 p/Share
|
Sep 11
2024 |
FLL
|
Daniel R Lee
PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 180,794 Reduced 10.22% |
$898,546
$4.97 p/Share
|
Sep 11
2024 |
FLL
|
Daniel R Lee
PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 718,834 Added 28.89% |
$898,542
$1.25 p/Share
|
Sep 11
2024 |
CDTX
|
Taylor Sandison
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 924 Reduced 3.85% |
$10,755
$11.64 p/Share
|
Sep 11
2024 |
ALHC
|
Robert Thomas Freeman
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 8,561 Reduced 0.0% |
$85,695
$10.01 p/Share
|
Sep 11
2024 |
ALHC
|
Christopher J Joyce
Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct | 34,626 Reduced 8.66% |
$336,910
$9.73 p/Share
|
Sep 11
2024 |
DDOG
|
Matthew Jacobson |
SELL
Open market or private sale
|
Indirect | 9,256 Reduced 0.0% |
$1,000,110
$108.05 p/Share
|
Sep 11
2024 |
DELL
|
Michael S Dell
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,602,535 Reduced 9.42% |
$172,288,537
$107.51 p/Share
|
Sep 11
2024 |
RMR
|
Adam D. Portnoy
Managing Dir., President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 12,249 Added 8.83% |
-
|
Sep 11
2024 |
RMR
|
Christopher J. Bilotto
Exec. VP of The RMR Group LLC |
BUY
Grant, award, or other acquisition
|
Direct | 6,124 Added 31.22% |
-
|
Sep 11
2024 |
RMR
|
John G. Murray
Exec. VP of The RMR Group LLC |
BUY
Grant, award, or other acquisition
|
Direct | 6,124 Added 14.9% |
-
|
Sep 11
2024 |
RMR
|
Jennifer B Clark
MD, Exec. VP, GC & Secty |
BUY
Grant, award, or other acquisition
|
Direct | 12,249 Added 16.39% |
-
|
Sep 11
2024 |
RMR
|
Matthew P. Jordan
Exec. VP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 12,249 Added 19.23% |
-
|
Sep 11
2024 |
TSSI
|
Kieran Brennan
Senior Vice President |
SELL
Open market or private sale
|
Direct | 27,450 Reduced 4.79% |
$132,309
$4.82 p/Share
|
Sep 11
2024 |
USFD
|
Dirk J. Locascio
EVP, Chief Financial Officer |
SELL
Bona fide gift
|
Indirect | 10,000 Reduced 0.0% |
-
|
Sep 11
2024 |
PBF
|
Control Empresarial De Capitales S.A. De C.V. |
BUY
Open market or private purchase
|
Direct | 670,000 Added 2.89% |
$20,964,300
$31.29 p/Share
|
Sep 11
2024 |
WMT
|
Jim C Walton
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 211,000 Reduced 0.0% |
-
|
Sep 11
2024 |
CTGO
|
Joseph S Compofelice |
SELL
Open market or private sale
|
Direct | 7,460 Reduced 4.78% |
$157,704
$21.14 p/Share
|
Sep 11
2024 |
SMMT
|
Jeff Huber
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 44,052 Added 0.0% |
$999,980
$22.7 p/Share
|
Sep 11
2024 |
SEAT
|
Lawrence Fey
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 40,071 Added 8.3% |
-
|
Sep 11
2024 |
XSPA
|
Gaelle Sandra Wizenberg
Director |
BUY
Open market or private purchase
|
Direct | 1,201 Added 44.47% |
$1,981
$1.65 p/Share
|
Sep 11
2024 |
WMT
|
Alice L Walton
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 211,000 Reduced 0.0% |
-
|
Sep 11
2024 |
OCCIO
|
Eagle Point Credit Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 189 Reduced 0.0% |
$4,622
$24.46 p/Share
|
Sep 11
2024 |
SEAT
|
Edward Pickus
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,720 Reduced 3.63% |
$7,017
$4.08 p/Share
|
Sep 11
2024 |
SEAT
|
Edward Pickus
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,504 Added 12.06% |
-
|
Sep 11
2024 |
WMG
|
Max Lousada
CEO, Recorded Music |
SELL
Open market or private sale
|
Direct | 250,769 Reduced 10.95% |
$7,044,101
$28.09 p/Share
|
Sep 11
2024 |
SEAT
|
Riva Bakal
Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,290 Reduced 4.68% |
$25,663
$4.08 p/Share
|
Sep 11
2024 |
SEAT
|
Riva Bakal
Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 21,432 Added 13.76% |
-
|
Sep 11
2024 |
SYY
|
Daniel Purefoy
SVP, Chief Supply Chain Off |
SELL
Payment of exercise price or tax liability
|
Direct | 90 Reduced 0.36% |
$7,065
$78.5 p/Share
|
Sep 11
2024 |
WMT
|
S Robson Walton
> 10% Shareholder |
SELL
Bona fide gift
|
Direct | 1,584,000 Reduced 18.39% |
-
|
Sep 11
2024 |
WMT
|
S Robson Walton
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 211,000 Reduced 0.0% |
-
|
Sep 11
2024 |
SEAT
|
Emily T Epstein
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,635 Reduced 7.38% |
$14,830
$4.08 p/Share
|
Sep 11
2024 |
SEAT
|
Emily T Epstein
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 7,845 Added 13.75% |
-
|
Sep 11
2024 |
SYY
|
Ronald L Phillips
EVP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct | 150 Reduced 0.5% |
$11,775
$78.5 p/Share
|
Sep 11
2024 |
SEAT
|
Stanley Chia
Chief Executive Officer |
SELL
Bona fide gift
|
Direct | 697,348 Reduced 100.0% |
-
|
Sep 11
2024 |
SEAT
|
Stanley Chia
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 69,982 Added 9.12% |
-
|
Sep 11
2024 |
SEAT
|
Stanley Chia
Chief Executive Officer |
BUY
Bona fide gift
|
Indirect | 697,348 Added 0.0% |
-
|
Sep 11
2024 |
SYY
|
Thomas R Peck Jr
EVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct | 250 Reduced 0.47% |
$19,625
$78.5 p/Share
|
Sep 11
2024 |
SMMT
|
Bhaskar Anand
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 22,026 Added 14.35% |
$499,990
$22.7 p/Share
|
Sep 11
2024 |
HROW
|
John P. Saharek
CEO of ImprimisRx |
SELL
Payment of exercise price or tax liability
|
Direct | 45,140 Reduced 13.09% |
$1,867,441
$41.37 p/Share
|
Sep 11
2024 |